Company: INCR
Filing Date: 2025-12-09
Form Type: SCHEDULE 13D
Source: 0001493152-25-026804
Chunk: 0

Company: Intercure Ltd.
Filing Date: 2025-12-09
Form: SCHEDULE 13D
Chunk 0
---
7,349,896 Ordinary Shares at an exercise price equal to NIS 5.70 (approximately $1.58), at an 18% premium above the opening price of the Ordinary Shares on the Determining Date, which may further increase the proceeds from the Private Placement up to a total of approximately NIS 77 million (approximately $21.5 million) if the Warrants are fully exercised for cash. The consideration for the allocated securities was determined through negotiations between the Company and the investors, based on the opening share price on the Determining Date. The Private Placement was subject to certain closing conditions, which included the approval of the shareholders of the Company, which was later obtained in February 2025. 
 The Private Placement closed on March 2, 2025. On March 2, 2025, following issuance of 2,070,393 Ordinary Shares and warrants exercisable into 2,070,393 Ordinary Shares in the Private Placement, Mr. Rabinovich became a beneficial owner of approximately 29.3% of the Ordinary Shares, reflecting an increase from the percentage owned as reported in our Annual Report on Form 20-F for the year ended December 31, 2023, which stated that as of April 1, 2024, Mr. Rabinovich beneficially owned 25.73%.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
 Mr. Rabinovich serves as the Chief Executive Officer, the Chairman and a director of the Issuer and is the Issuer's majority shareholder. Mr. Rabinovich also controls DIM, holds shared voting and dispositive power over the securities held by DIM and may be deemed to be the controlling shareholder over the securities held by DIM. Accordingly, the Reporting Persons may have influence over the corporate activities of the Issuer, including activities that may relate to items described in clauses (a) through (j) of Item 4 of Schedule 13D. Except for the foregoing, the Reporting Persons have no plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) and (c) through (j) of Item 4 of Schedule 13D. The Reporting Persons reserve the right to formulate plans and/or proposals and to take such actions with respect to their investment in the Issuer, including any or all of the actions set forth in clauses (a) through (j) of Item 4 of Schedule 13D.                                                                                                                                                                                                                                                                                            
 In his capacity as the Chief Executive Officer the Chairman